Navigation Links
Express Scripts Holding Company Announces First Quarter 2013 Earnings Conference Call
Date:4/22/2013

ST. LOUIS, April 22, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its first quarter earnings on Monday, April 29, 2013 after the market closes and will hold its quarterly conference call to discuss first quarter results on Tuesday, April 30, 2013, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time).

This call is being webcast and can be accessed at Express Scripts' web site at www.express-scripts.com/corporate

About Express Scripts

Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision ScienceSM, our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more informatio
'/>"/>

SOURCE Express Scripts Holding Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Express Scripts to Present at Bank of America Merrill Lynch Conference
2. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
3. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
4. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
5. Generex Augments Antigen Express Scientific Advisory Board
6. Law Office of Brodsky & Smith, LLC Announces Investigation of SRI Surgical Express, Inc.
7. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
8. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
9. Express Scripts Holding Company Announces Second Quarter 2012 Earnings Conference Call
10. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
11. Express Scripts Reports Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... FT LAUDERDALE, Florida , July 1, 2015 /PRNewswire/ ... manufacturer and marketer of innovative medical devices for the treatment ... it prevailed in a final opposition appeal hearing in the ... 482 - STENT HAVING HELICAL ELEMENTS (,482). The ,482 patent ... and has been upheld as a valid patent in amended ...
(Date:7/1/2015)... 1, 2015 Qiming Venture Partners, today announces ... Partner effective immediately. William has been with ... participated in many Qiming healthcare deals, and assisted many ... market. Qiming, s success in healthcare is not a ... himself with his outstanding advocacy and service mentality on ...
(Date:7/1/2015)... , June 24, 2015 ... the addition of the "Future Horizons and ... 2015: Supplier Shares and Country Forecasts" report ... Growth Strategies in the European Blood Banking Market ... order to help current suppliers and potential market ...
Breaking Medicine Technology:OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2Qiming Announces the Promotion of William Hu to Managing Partner 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3
... Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), ... Data Safety Monitoring Board (DSMB) recently completed a ... Soligenix,s confirmatory Phase 3 clinical trial of orBec® ... acute gastrointestinal Graft-versus-Host disease (GI GVHD). ...
... CHAPEL HILL, N.C., Sept. 15, 2011 Cempra ... clinical trial investigating the efficacy, safety and tolerability ... solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with ... pneumonia (CABP).  In the Phase II trial, CEM-101 ...
Cached Medicine Technology:Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 2Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 4Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 5Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 6Cempra Announces Comparable Efficacy of Oral Solithromycin (CEM-101) Compared with Levofloxacin in Phase II Clinical Trial in Patients with Community-Acquired Bacterial Pneumonia (CABP) 2Cempra Announces Comparable Efficacy of Oral Solithromycin (CEM-101) Compared with Levofloxacin in Phase II Clinical Trial in Patients with Community-Acquired Bacterial Pneumonia (CABP) 3
(Date:7/1/2015)... ... July 01, 2015 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... welcome four new members to their industry leading Scientific Advisory Board. LRF’s volunteer ...
(Date:7/1/2015)... ... ... Dr. Surya Challa of Chesapeake Vein Center and MedSpa in Chesapeake, VA will ... non-invasive CoolSculpting . On the show, Dr. Challa will explain how CoolSculpting can ... Cryolipolysis to literally freeze stubborn, unwanted fat away and give patients the slim, trim ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... training leaders Lora Posey (Manager, National Sales Training and Development) and Chuck Corso ... Network (LTEN) Conference in Phoenix, AZ. LTEN brings together learning and development professionals ...
(Date:7/1/2015)... ... July 01, 2015 , ... Convoy of Hope will partner ... Twin Cities on Saturday, August 1, at Spring Lake Park High School. , During ... than $1 million worth of goods and services including free food, health services, family ...
(Date:7/1/2015)... ... July 01, 2015 , ... Element ... products, announced today that it has received trademark protection for its SensorInsight® computer ... analysis of data from multiple sources providing an environment where users can view ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4
... ... shifting benefits programs. , ... Indianapolis, IN (PRWEB) August 1, 2009 -- Member Firms of United Benefit ... announced that registration for the August webinar titled "Electronic Distribution of SPDs and other ...
... ... K. Riegelman, is hard-wired to the Association of American Colleges and Universities, ... is an important part of a growing movement of several prominent higher ... critical component of good citizenship and a prerequisite for taking responsibility for ...
... MD (August 1, 2009) The antidiabetic medication metformin ... in diabetics, according to a new study in ... Association (AGA) Institute. However, other commonly used therapies, such ... increased risk for the deadly disease. "The current ...
... struggle with CPAP treatment for obstructive sleep apnea (OSA) ... upper airway, because it holds the same quality-of-life (QOL) ... new research published in the August 2009 edition of ... airway pressure (CPAP) therapy is a highly effective means ...
... WASHINGTON, July 31 Pharmaceutical Research and Manufacturers of America ... after the Energy and Commerce Committee mark-up of the House ... to working with the Administration and Congress to help enact ... with the White House and the Senate Finance Committee, which ...
... , "With one-third of Hispanic ... , WASHINGTON, July 31 With one-third of Hispanic ... Congress to work through its planned August recess to streamline America,s ... adults without health coverage, this is no time for a vacation," ...
Cached Medicine News:Health News:Webinar Offers Tips for Meeting Compliance Communications and Provides HRCI Credit for Human Resource Professionals 2Health News:Webinar Offers Tips for Meeting Compliance Communications and Provides HRCI Credit for Human Resource Professionals 3Health News:New Book by Leading Authority Responds to National Initiative to Bring Undergraduate Public Health Education to All American Colleges and Universities 2Health News:New Book by Leading Authority Responds to National Initiative to Bring Undergraduate Public Health Education to All American Colleges and Universities 3Health News:Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others 2Health News:House Tri-Committee Bill Would Hurt Patients and Kill Jobs 2Health News:House Tri-Committee Bill Would Hurt Patients and Kill Jobs 3Health News:Hispanic Alliance Urges Congress to Work Through Recess on Health 2
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
For the quantitative in vitro determination of creatinine in serum, plasma or urine....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
Medicine Products: